Cargando…
Five Month-Persistent Extrapyramidal Symptoms following a Single Injection of Paliperidone Palmitate: A Case Report
Long-acting injectable (LAI) antipsychotics are useful in the treatments for schizophrenic patients with poor adherence due to their maintaining feature of therapeutic plasma level without daily administrations. However, their long-lasting property can cause complicated problems such as a long-lasti...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean College of Neuropsychopharmacology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5565081/ https://www.ncbi.nlm.nih.gov/pubmed/28783941 http://dx.doi.org/10.9758/cpn.2017.15.3.288 |
_version_ | 1783258360466898944 |
---|---|
author | Jang, Seoyoung Woo, Jungmin |
author_facet | Jang, Seoyoung Woo, Jungmin |
author_sort | Jang, Seoyoung |
collection | PubMed |
description | Long-acting injectable (LAI) antipsychotics are useful in the treatments for schizophrenic patients with poor adherence due to their maintaining feature of therapeutic plasma level without daily administrations. However, their long-lasting property can cause complicated problems such as a long-lasting side effect. We report a patient who experienced LAI-induced extrapyramidal symptoms (EPSs) for 5 months after a single injection. During that period, every trial to ameliorate this condition turned out to be a failure. The 3-month formulation of paliperidone palmitate is now close at hand. We have to be aware of possible long-lasting adverse events and confirm the tolerability to LAI before use. |
format | Online Article Text |
id | pubmed-5565081 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Korean College of Neuropsychopharmacology |
record_format | MEDLINE/PubMed |
spelling | pubmed-55650812017-08-23 Five Month-Persistent Extrapyramidal Symptoms following a Single Injection of Paliperidone Palmitate: A Case Report Jang, Seoyoung Woo, Jungmin Clin Psychopharmacol Neurosci Case Report Long-acting injectable (LAI) antipsychotics are useful in the treatments for schizophrenic patients with poor adherence due to their maintaining feature of therapeutic plasma level without daily administrations. However, their long-lasting property can cause complicated problems such as a long-lasting side effect. We report a patient who experienced LAI-induced extrapyramidal symptoms (EPSs) for 5 months after a single injection. During that period, every trial to ameliorate this condition turned out to be a failure. The 3-month formulation of paliperidone palmitate is now close at hand. We have to be aware of possible long-lasting adverse events and confirm the tolerability to LAI before use. Korean College of Neuropsychopharmacology 2017-08 2017-08-31 /pmc/articles/PMC5565081/ /pubmed/28783941 http://dx.doi.org/10.9758/cpn.2017.15.3.288 Text en Copyright © 2017, Korean College of Neuropsychopharmacology This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Jang, Seoyoung Woo, Jungmin Five Month-Persistent Extrapyramidal Symptoms following a Single Injection of Paliperidone Palmitate: A Case Report |
title | Five Month-Persistent Extrapyramidal Symptoms following a Single Injection of Paliperidone Palmitate: A Case Report |
title_full | Five Month-Persistent Extrapyramidal Symptoms following a Single Injection of Paliperidone Palmitate: A Case Report |
title_fullStr | Five Month-Persistent Extrapyramidal Symptoms following a Single Injection of Paliperidone Palmitate: A Case Report |
title_full_unstemmed | Five Month-Persistent Extrapyramidal Symptoms following a Single Injection of Paliperidone Palmitate: A Case Report |
title_short | Five Month-Persistent Extrapyramidal Symptoms following a Single Injection of Paliperidone Palmitate: A Case Report |
title_sort | five month-persistent extrapyramidal symptoms following a single injection of paliperidone palmitate: a case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5565081/ https://www.ncbi.nlm.nih.gov/pubmed/28783941 http://dx.doi.org/10.9758/cpn.2017.15.3.288 |
work_keys_str_mv | AT jangseoyoung fivemonthpersistentextrapyramidalsymptomsfollowingasingleinjectionofpaliperidonepalmitateacasereport AT woojungmin fivemonthpersistentextrapyramidalsymptomsfollowingasingleinjectionofpaliperidonepalmitateacasereport |